
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
Simon Jasinski‐Bergner, Adi Reches, Robert Stoehr, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 26866-26878
Open Access | Times Cited: 46
Simon Jasinski‐Bergner, Adi Reches, Robert Stoehr, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 26866-26878
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens, Paolo A. Ascierto, Phillip K. Darcy, et al.
European Journal of Cancer (2017) Vol. 81, pp. 116-129
Closed Access | Times Cited: 506
Leisha A. Emens, Paolo A. Ascierto, Phillip K. Darcy, et al.
European Journal of Cancer (2017) Vol. 81, pp. 116-129
Closed Access | Times Cited: 506
Deregulation of HLA-I in cancer and its central importance for immunotherapy
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 138
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 138
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 138
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 138
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
Fabio Morandi, Roberta Rizzo, Enrico Fainardi, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-14
Open Access | Times Cited: 118
Fabio Morandi, Roberta Rizzo, Enrico Fainardi, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-14
Open Access | Times Cited: 118
The role of the miR‐148/‐152 family in physiology and disease
Michael Friedrich, Katharina Pracht, Mir‐Farzin Mashreghi, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 12, pp. 2026-2038
Open Access | Times Cited: 108
Michael Friedrich, Katharina Pracht, Mir‐Farzin Mashreghi, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 12, pp. 2026-2038
Open Access | Times Cited: 108
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
Esther Schwich, Vera Rebmann, Rafael Tomoya Michita, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Esther Schwich, Vera Rebmann, Rafael Tomoya Michita, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 103
The Role of miRNAs in Immune Cell Development, Immune Cell Activation, and Tumor Immunity: With a Focus on Macrophages and Natural Killer Cells
Shi‐Jun Xu, Hong-Tao Hu, Hai Liang Li, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1140-1140
Open Access | Times Cited: 63
Shi‐Jun Xu, Hong-Tao Hu, Hai Liang Li, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1140-1140
Open Access | Times Cited: 63
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Michael Friedrich, Simon Jasinski‐Bergner, Maria‐Filothei Lazaridou, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1689-1700
Closed Access | Times Cited: 62
Michael Friedrich, Simon Jasinski‐Bergner, Maria‐Filothei Lazaridou, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1689-1700
Closed Access | Times Cited: 62
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Antonella Argentiero, Antonio Giovanni Solimando, Markus Krebs, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1594-1594
Open Access | Times Cited: 61
Antonella Argentiero, Antonio Giovanni Solimando, Markus Krebs, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1594-1594
Open Access | Times Cited: 61
Molecular mechanisms of HLA class I‐mediated immune evasion of human tumors and their role in resistance to immunotherapies
Barbara Seliger
HLA (2016) Vol. 88, Iss. 5, pp. 213-220
Closed Access | Times Cited: 50
Barbara Seliger
HLA (2016) Vol. 88, Iss. 5, pp. 213-220
Closed Access | Times Cited: 50
HLA‐G: Function, polymorphisms and pathology
Antonio Arnaiz‐Villena, Ignacio Juárez, Fabio Suárez‐Trujillo, et al.
International Journal of Immunogenetics (2020) Vol. 48, Iss. 2, pp. 172-192
Open Access | Times Cited: 49
Antonio Arnaiz‐Villena, Ignacio Juárez, Fabio Suárez‐Trujillo, et al.
International Journal of Immunogenetics (2020) Vol. 48, Iss. 2, pp. 172-192
Open Access | Times Cited: 49
NK cells in renal cell carcinoma and its implications for CAR-NK therapy
Xinwei Li, Yuanpeng Zhang, Yuzhong Ye, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Xinwei Li, Yuanpeng Zhang, Yuzhong Ye, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Identification and Characterization of the RNA Modifying Factors PUS7 and WTAP as Key Components for the Control of Tumor Biological Processes in Renal Cell Carcinomas
Tim Hohmann, Urszula Grabiec, Faramarz Dehghani, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 266-266
Open Access
Tim Hohmann, Urszula Grabiec, Faramarz Dehghani, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 266-266
Open Access
Haplotypes of the HLA-G 3’ Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially
Isabelle Poras, Layale Yaghi, Gustavo Martelli‐Palomino, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169032-e0169032
Open Access | Times Cited: 43
Isabelle Poras, Layale Yaghi, Gustavo Martelli‐Palomino, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169032-e0169032
Open Access | Times Cited: 43
Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy
Hyung-Joon Kwon, Nayoung Kim, Hun Sik Kim
Experimental & Molecular Medicine (2017) Vol. 49, Iss. 3, pp. e311-e311
Open Access | Times Cited: 41
Hyung-Joon Kwon, Nayoung Kim, Hun Sik Kim
Experimental & Molecular Medicine (2017) Vol. 49, Iss. 3, pp. e311-e311
Open Access | Times Cited: 41
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients
Maria‐Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Maria‐Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Role of HLA-G in Viral Infections
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
RNA-Sequenzierung zur Analyse Epstein-Barr-Virus-codierter microRNAs
Tim Hohmann, Simon Jasinski‐Bergner
BIOspektrum (2025) Vol. 31, Iss. 1, pp. 45-48
Open Access
Tim Hohmann, Simon Jasinski‐Bergner
BIOspektrum (2025) Vol. 31, Iss. 1, pp. 45-48
Open Access
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744
Michael Friedrich, Christoforos Vaxevanis, Katharina Biehl, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000396-e000396
Open Access | Times Cited: 29
Michael Friedrich, Christoforos Vaxevanis, Katharina Biehl, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000396-e000396
Open Access | Times Cited: 29
The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
Simon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Simon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Role of HLA-G in tumors and upon COVID-19 infection
Barbara Seliger
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110792-110792
Open Access | Times Cited: 3
Barbara Seliger
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110792-110792
Open Access | Times Cited: 3
Molecular mechanisms of human herpes viruses inferring with host immune surveillance
Simon Jasinski‐Bergner, Ofer Mandelboim, Barbara Seliger
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000841-e000841
Open Access | Times Cited: 25
Simon Jasinski‐Bergner, Ofer Mandelboim, Barbara Seliger
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000841-e000841
Open Access | Times Cited: 25
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma
Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2690-2690
Open Access | Times Cited: 25
Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2690-2690
Open Access | Times Cited: 25
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 14
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 14
An Insight Into the Whole Transcriptome Profile of Four Tissue-Specific Human Mesenchymal Stem Cells
Dana Alhattab, Fatima Jamali, Dema Ali, et al.
Regenerative Medicine (2019) Vol. 14, Iss. 9, pp. 841-865
Closed Access | Times Cited: 22
Dana Alhattab, Fatima Jamali, Dema Ali, et al.
Regenerative Medicine (2019) Vol. 14, Iss. 9, pp. 841-865
Closed Access | Times Cited: 22